Micellar nanoparticles loaded with gemcitabine and doxorubicin showed synergistic effect

Colloids and Surfaces B: Biointerfaces

Volumn 113, Issue , 2014, Pages 158-168

  Liu, Dechun ^a   Chen, Yanbin ^a   Feng, Xiaoshan ^a   Deng, Miao ^a   Xie, Gangqiang ^a   Wang, Jianguang ^a   Zhang, Like ^a   Liu, Qipeng ^a   Yuan, Pengfei ^a  

^a HENAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Doxorubicin; Drug delivery; Gemcitabine; Micelles; Polymer conjugates

Indexed keywords

BIODEGRADABLE POLYMERS; DRUG DELIVERY; MICELLES;

ANTICANCER DRUG; DOXORUBICIN; GEMCITABINE; MICELLAR NANOPARTICLES; MTT ASSAYS; POLYMER CONJUGATE; SELF-ASSEMBLE; SYNERGISTIC EFFECT;

DRUG PRODUCTS;

DOXORUBICIN; DRUG CARRIER; GENTAMICIN; NANOPARTICLE; POLYMER;

ARTICLE; BIOCOMPATIBILITY; CELL STRAIN HEPG2; CELL STRAIN MCF 7; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG POTENTIATION; DRUG RELEASE; DRUG UPTAKE; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; MICELLIZATION; PRIORITY JOURNAL;

DOXORUBICIN; DRUG DELIVERY; GEMCITABINE; MICELLES; POLYMER CONJUGATES;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL SURVIVAL; DEOXYCYTIDINE; DOXORUBICIN; DRUG CARRIERS; HEP G2 CELLS; HUMANS; MICELLES; NANOPARTICLES;

EID: 84884937777     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2013.08.010     Document Type: Article

References (54)

1. Hui R.H., Reitz J. Am. J. Health-Syst. Pharm. 1997, 54:162.
2. Heinemann V., Hertel L.W., Grindey G.B., et al. Cancer Res. 1988, 48:4024.
3. Matsuda A., Sasaki T. Cancer Sci. 2004, 95:105.
4. Plunkett W., Huang P., Xu Y.Z., Heinemann V., et al. Semin. Oncol. 1995, 22:3.
5. Reddy L., Couvreur P. Curr. Pharm. Des. 2008, 14:1124.
6. Immordino M.L., Brusa P., Rocco F., et al. J. Control. Release 2004, 100:331.
7. Kim I.Y., Kang Y.S., Lee D.S., et al. J. Control. Release 2009, 140:55.
8. Storniolo A.M., Allerheiligen S.R.P., Pearce H.L. Semin. Oncol. 1997, 24. S7-2.
9. Robinson K., Lambiase L., Li J., et al. Dig. Dis. Sci. 2003, 48:1804.
10. Bonner J.A., Liengswangwong V. Biochem. Biophys. Res. Commun. 1994, 198:582.
11. Kasahara K., Fujiwara Y., Sugimoto Y., Nishio K., et al. J. Natl. Cancer Inst. 1992, 84:113.
12. Foglesong P.D., Reckord C., Swink S. Cancer Chemother. Pharmacol. 1992, 30:123.
13. Lou P.J., La P.S., Shieh M.J., et al. Cancer Chemother. Pharmacol. 2006, 119:2692.
14. Stebbing J., Gaya A. Cancer Treat. Rev. 2002, 28:121.
15. Dong Z.L., Yang K.H., Liu Y., et al. Cochrane Database Syst. Rev. 2010, 1:CD008181.
16. Roth A.D., Herrmann R., Morant R., et al. Eur. J. Cancer 1998, 34:2126.
17. Valle J.W., Dangoor A., Beech J., et al. Br. J. Cancer 2005, 92:628.
18. Weh H.J., DeWit, Zornig C., Hossfeld D.K. Onkologie 1996, 19:159.
19. Massart C., Barbet R., Genetet N., et al. Thyroid 2004, 14:263.
20. Tennvall J., Lundell G., Wahlberg P., et al. Br. J. Cancer 2002, 86:1848.
21. Bally M.B., Nayer R., Masin D., et al. Cancer Chemother. Pharmacol. 1990, 27:13.
22. Arcamone F. Biotechnol. Bioeng. 1969, 11:1101.
23. Cortes-Funes H., Coronado C. Cardiovasc. Toxicol. 2007, 7:56.
24. Mitani I., Jain D., Joska T.M., et al. J. Nucl. Cardiol. 2003, 10:132.
25. Kang Y.J., Chen Y., Epstein P.N. J. Biol. Chem. 1996, 271:12610.
26. Kesik V., Kurt B., Tunc T., et al. Ann. Plast. Surg. 2010, 65:250.
27. Wang L., Shi J., Zhang H., et al. Biomaterials 2013, 34:262.
28. Posthumadeboer J., van Egmond P.W., Helder M.N. Oncotarget 2012, 3:1169.
29. Muktapuram P.R., Gara R.K., Sharma K. Eur. J. Med. Chem. 2012, 56:400.
30. Kurata H., Takakuwa K., Tsuneki I., et al. Int. J. Gynecol. Cancer 2000, 10:459.
31. Sawada S., Mese H., Sasaki A. Cancer Chemother. Pharmacol. 2003, 51:505.
32. Chun R., Kurzman I.D., Couto C.G. J. Vet. Intern. Med. 2000, 14:495.
33. Minotti G., Saponiero A., Licata S., et al. Clin. Cancer Res. 2001, 7:1511.
34. Pérez-Manga G., Lluch A., Alba E., et al. J. Clin. Oncol. 2000, 18:2545.
35. Lombardi G., Zustovich F., Farinati F., et al. Cancer 2011, 1:125.
36. Lammers T., Subr V., Ulbrich K., et al. Biomaterials 2009, 3:3466.
37. Liu L., Li C., Li X., et al. J. Appl. Polym. Sci. 2001, 80:1976.
38. Yang L., Wu X., Liu F., et al. Pharm. Res. 2009, 26:2332.
39. Pharmacie F., Montréal U. Molecules 2005, 10:98.
40. Ben-Shabat S., Kumar N., Domb A.J. Macromol. Biosci. 2006, 6:1019.
41. Gao X., Kan B., Gou M., Zhang J., Guo G., Huang N., Zhao X., Qian Z. J. Biomed. Nanotechnol. 2011, 7:285.
42. Wu L., Zou Y., Deng C., Cheng R., Meng F., Zhong Z. Biomaterials 2013, 34:5262.
43. Couvreur P., Gref R., Andrieux K., et al. Prog. Solid State Chem. 2006, 34:231.
44. Li K.C., Pandit S.D. Biomed. Microdevices 2004, 6:113.
45. Muldoon L.L., Tratnyek P.G., Jacobs P.M. Am. J. Neuroradiol. 2006, 27:715.
46. Khemtong C., Kessinger C.W., Gao J. Chem. Commun. 2009, 24:3497.
47. Pasut G., Canal F., Via L.D., et al. J. Control. Release 2008, 127:239.
48. Saito H., Hoffman A.S., Ogawa H.I. J. Bioact. Compat. Polym. 2007, 22:589.
49. Torchilin V. Adv. Drug Deliv. Rev. 2011, 63:131.
50. Khaled G. J. Drug Target. 2007, 15:457.
51. Sethuraman V.A., Lee M.C., Bae Y.H. Pharm. Res. 2005, 25:657.
52. Vicent M.J., Greco F., Nicholson R.I. Angew. Chem. Int. Ed. 2005, 117:4129.
53. Zhao L., Wientjes M.G., Au J.L.S. Clin. Cancer Res. 2004, 10:7994.
54. Chou T.C., Talalay P. Trends Pharmacol. Sci. 1983, 4:450-454.